Connect your AI

Aurinia Pharmaceuticals AUPH Price / sales

Price / sales at other companies

Rogers CorporationROG

2.3×+0.8×

Ultragenyx PharmaceuticalRARE

3.1×-2.7×

Agios PharmaceuticalsAGIO

30×-15.3×

BridgeBio PharmaBBIO

24.8×-26.8×

Kiniksa Pharmaceuticals International, plcKNSA

4.9×+1.5×

Alumis Inc.ALMS

333.5×—

Other financials

Income statement

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

Operating cash flow$32.6M+2,405%

Valuation

Market cap$2.3B+78.5%

Enterprise value$2.34B+78.3%

P/E7.7×-24.6×

Profitability

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Calculated from Aurinia Pharmaceuticals’s reported figures.

market cap/total revenue=6.6×

Based on the most recent quarter.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Aurinia Pharmaceuticals's price / sales?: Aurinia Pharmaceuticals (AUPH) reported price / sales of 6.6× in Q1 2026.
How has Aurinia Pharmaceuticals's price / sales changed year-over-year?: Aurinia Pharmaceuticals's price / sales increased by 48.0% year-over-year, from 4.5× to 6.6×.
What is the long-term trend for Aurinia Pharmaceuticals's price / sales?: Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's price / sales has grown at a -28.4% compound annual growth rate (CAGR), from 39.5× to 7.4×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.